COP Stock Overview
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide.
CompuGroup Medical SE KGaA Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€43.60|
|52 Week High||€82.80|
|52 Week Low||€36.30|
|1 Month Change||3.71%|
|3 Month Change||-12.06%|
|1 Year Change||-41.24%|
|3 Year Change||-17.19%|
|5 Year Change||-9.71%|
|Change since IPO||440.39%|
Recent News & Updates
CompuGroup Medical SE KGaA (ETR:COP) Has A Pretty Healthy Balance Sheet
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
|COP||DE Healthcare Services||DE Market|
Return vs Industry: COP underperformed the German Healthcare Services industry which returned -36.9% over the past year.
Return vs Market: COP underperformed the German Market which returned -20% over the past year.
|COP Average Weekly Movement||6.2%|
|Healthcare Services Industry Average Movement||5.1%|
|Market Average Movement||5.7%|
|10% most volatile stocks in DE Market||10.7%|
|10% least volatile stocks in DE Market||2.8%|
Stable Share Price: COP is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: COP's weekly volatility (6%) has been stable over the past year.
About the Company
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions.
CompuGroup Medical SE KGaA Fundamentals Summary
|COP fundamental statistics|
Is COP overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|COP income statement (TTM)|
|Cost of Revenue||€726.83m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Nov 03, 2022
|Earnings per share (EPS)||1.36|
|Net Profit Margin||6.37%|
How did COP perform over the long term?See historical performance and comparison
1.1%Current Dividend Yield
Is COP undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for COP?
Other financial metrics that can be useful for relative valuation.
|What is COP's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does COP's PE Ratio compare to its peers?
|COP PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
M3V MeVis Medical Solutions
COP CompuGroup Medical SE KGaA
Price-To-Earnings vs Peers: COP is expensive based on its Price-To-Earnings Ratio (32x) compared to the peer average (23.5x).
Price to Earnings Ratio vs Industry
How does COP's PE Ratio compare vs other companies in the European Healthcare Services Industry?
Price-To-Earnings vs Industry: COP is expensive based on its Price-To-Earnings Ratio (32x) compared to the German Healthcare Services industry average (30.6x)
Price to Earnings Ratio vs Fair Ratio
What is COP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||32x|
|Fair PE Ratio||24.4x|
Price-To-Earnings vs Fair Ratio: COP is expensive based on its Price-To-Earnings Ratio (32x) compared to the estimated Fair Price-To-Earnings Ratio (24.4x).
Share Price vs Fair Value
What is the Fair Price of COP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: COP (€43.6) is trading below our estimate of fair value (€77.47)
Significantly Below Fair Value: COP is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
How is CompuGroup Medical SE KGaA forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COP's forecast earnings growth (18.1% per year) is above the savings rate (-0.01%).
Earnings vs Market: COP's earnings (18.1% per year) are forecast to grow faster than the German market (7.9% per year).
High Growth Earnings: COP's earnings are forecast to grow, but not significantly.
Revenue vs Market: COP's revenue (4.5% per year) is forecast to grow slower than the German market (4.6% per year).
High Growth Revenue: COP's revenue (4.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: COP's Return on Equity is forecast to be low in 3 years time (16.7%).
Discover growth companies
How has CompuGroup Medical SE KGaA performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: COP has high quality earnings.
Growing Profit Margin: COP's current net profit margins (6.4%) are lower than last year (7.4%).
Past Earnings Growth Analysis
Earnings Trend: COP's earnings have grown by 7.7% per year over the past 5 years.
Accelerating Growth: COP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: COP had negative earnings growth (-1.7%) over the past year, making it difficult to compare to the Healthcare Services industry average (-1.7%).
Return on Equity
High ROE: COP's Return on Equity (11.4%) is considered low.
Discover strong past performing companies
How is CompuGroup Medical SE KGaA's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: COP's short term assets (€411.1M) do not cover its short term liabilities (€474.4M).
Long Term Liabilities: COP's short term assets (€411.1M) do not cover its long term liabilities (€829.9M).
Debt to Equity History and Analysis
Debt Level: COP's net debt to equity ratio (103.2%) is considered high.
Reducing Debt: COP's debt to equity ratio has reduced from 161.8% to 122.4% over the past 5 years.
Debt Coverage: COP's debt is not well covered by operating cash flow (18.3%).
Interest Coverage: COP earns more interest than it pays, so coverage of interest payments is not a concern.
Discover healthy companies
What is CompuGroup Medical SE KGaA current dividend yield, its reliability and sustainability?
Dividend Score 4/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: COP's dividend (1.15%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.46%).
High Dividend: COP's dividend (1.15%) is low compared to the top 25% of dividend payers in the German market (4.4%).
Stability and Growth of Payments
Stable Dividend: COP's dividends per share have been stable in the past 10 years.
Growing Dividend: COP's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (36.9%), COP's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (45.3%), COP's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
CompuGroup Medical SE KGaA has no CEO, or we have no data on them.
Experienced Management: COP's management team is considered experienced (2.6 years average tenure).
Experienced Board: COP's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CompuGroup Medical SE & Co. KGaA's employee growth, exchange listings and data sources
- Name: CompuGroup Medical SE & Co. KGaA
- Ticker: COP
- Exchange: XTRA
- Founded: 1987
- Industry: Health Care Technology
- Sector: Healthcare
- Implied Market Cap: €2.277b
- Shares outstanding: 52.24m
- Website: https://www.cgm.com
Number of Employees
- CompuGroup Medical SE & Co. KGaA
- Maria Trost 21
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/08 00:00|
|End of Day Share Price||2022/08/08 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.